BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37994752)

  • 21. Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision.
    Hsieh JJ; Le V; Cao D; Cheng EH; Creighton CJ
    J Pathol; 2018 Apr; 244(5):525-537. PubMed ID: 29266437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood-Based Multiomics-Guided Detection of a Precancerous Pancreatic Tumor.
    Anwar MA; Keshteli AH; Yang H; Wang W; Li X; Messier HM; Cullis PR; Borchers CH; Fraser R; Wishart DS
    OMICS; 2024 Apr; 28(4):182-192. PubMed ID: 38634790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic cancer: challenges and opportunities.
    Zhu H; Li T; Du Y; Li M
    BMC Med; 2018 Nov; 16(1):214. PubMed ID: 30463539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omics sciences and precision medicine in Urothelial Carcinoma.
    Medori MC; Micheletti C; Madeo G; Maltese PE; Tanzi B; Tezzele S; Mareso C; Generali D; Donofrio CA; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Ahmed R; Ahmed R; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):1-10. PubMed ID: 37994743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omics sciences and precision medicine in sarcoma.
    Bonetti G; Donato K; Dhuli K; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Bernini A; Fulcheri E; Cavalca D; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):68-76. PubMed ID: 37994750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers for personalized medicine in GI cancers.
    Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
    Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Precision medicine for psychopharmacology: a general introduction.
    Shin C; Han C; Pae CU; Patkar AA
    Expert Rev Neurother; 2016 Jul; 16(7):831-9. PubMed ID: 27104961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.
    Court CM; Ankeny JS; Hou S; Tseng HR; Tomlinson JS
    Expert Rev Mol Diagn; 2015; 15(11):1491-504. PubMed ID: 26390158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic cancer genomics.
    Chang DK; Grimmond SM; Biankin AV
    Curr Opin Genet Dev; 2014 Feb; 24():74-81. PubMed ID: 24480245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omics for the future in asthma.
    Abdel-Aziz MI; Neerincx AH; Vijverberg SJ; Kraneveld AD; Maitland-van der Zee AH
    Semin Immunopathol; 2020 Feb; 42(1):111-126. PubMed ID: 31942640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Path to Personalized Medicine for Type 2 Diabetes Mellitus: Reality and Hope.
    Aghaei Meybodi HR; Hasanzad M; Larijani B
    Acta Med Iran; 2017 Mar; 55(3):166-174. PubMed ID: 28282717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organoid model: A new hope for pancreatic cancer treatment?
    Chen H; Zhuo Q; Ye Z; Xu X; Ji S
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188466. PubMed ID: 33160014
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetics of pancreatic cyst-cancer progression: standing on the shoulders of giants.
    Giri B; Sethi V; Dudeja V; Banerjee S; Livingstone A; Saluja A
    Curr Opin Gastroenterol; 2017 Sep; 33(5):404-410. PubMed ID: 28682795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precision medicine and bladder cancer heterogeneity.
    Ma G; Yang X; Liang Y; Wang L; Li D; Chen Y; Liang Z; Wang Y; Niu H
    Bull Cancer; 2018 Oct; 105(10):925-931. PubMed ID: 30243478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision omics data integration and analysis with interoperable ontologies and their application for COVID-19 research.
    Wang Z; He Y
    Brief Funct Genomics; 2021 Jul; 20(4):235-248. PubMed ID: 34159360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Practice and challenge of precision medicine for pancreatic cancer].
    Shi XH; Jin G
    Zhonghua Wai Ke Za Zhi; 2020 Jan; 58(1):37-41. PubMed ID: 31902168
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and Treatment of Breast Cancer in the Precision Medicine Era.
    Yan J; Liu Z; Du S; Li J; Ma L; Li L
    Methods Mol Biol; 2020; 2204():53-61. PubMed ID: 32710314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go.
    Thompson ED; Roberts NJ; Wood LD; Eshleman JR; Goggins MG; Kern SE; Klein AP; Hruban RH
    Mod Pathol; 2020 Dec; 33(12):2544-2563. PubMed ID: 32704031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precision Medicine for Pancreas Cancer Treatment: A Multidisciplinary Challenge or Opportunity?
    Farrell JJ; Robert ME; Lacy J
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2740-2742. PubMed ID: 36640803
    [No Abstract]   [Full Text] [Related]  

  • 40. Pancreas Cancer Precision Treatment Using Avatar Mice from a Bioinformatics Perspective.
    Perales-Patón J; Piñeiro-Yañez E; Tejero H; López-Casas PP; Hidalgo M; Gómez-López G; Al-Shahrour F
    Public Health Genomics; 2017; 20(2):81-91. PubMed ID: 28858862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.